Stock search

Ticker or company name

Compare stocks

Market: US

  • EWEdwards Lifesciences

Add stock

Ticker or company

Summary

EW
Edwards Lifesciences
$107,11Down −0,04%
Year: Up +24%
56/100Ratio would watch
Open stock page

Traffic light — 10 checks

CheckEW5 ✓ 0 — 4 ✕
P/E vs its history60,3
P/E vs industry60,3
Forward P/E35,5
Revenue growth, YoY+13,4%
EPS growth, YoY−23,7%
Net margin15,2%
Net debt / EBITDA−2,5
Free cash flow$1,42 bn
Share count over a year−1,4%
Cash runwayn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterEWTTMIndustry medianTTM
P/E TTM ↓60,325,1
Forward P/E ↓35,516,2
PEG ↓n/a2,2
P/S TTM ↓9,22,2
EV/EBITDA ↓43,817,3
P/FCF ↓42,619,5

Price, %

  • EWn/a

Returns

Best WorstNo mark — in between

PeriodEW
1 yearn/a
3 yearsn/a
5 yearsn/a
All timen/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

EW
Share of “buy”82%
Beat the forecast3 of 4
Average “surprise”+0,7%
Insiders over 12 monthssales $34,0 m

Details are on each stock page.